GATC Health
GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. Trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners, GATC Health’s risk prediction product, the Derisq™ AI report, accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. GATC Health’s AI platform is also generative, creating intellectual property, extending pipelines, and optimizing assets. By uniting advanced AI, multiomics, and predictive modeling, GATC Health accelerates breakthroughs and reduces costly late-stage failures to bring safer, more effective therapies to patients worldwide. For more information, visit www.gatchealth.com.
What is your next catalyst (value inflection) update?
n/a
Year Founded
2020
Lead Product in Development
n/a
Development Phase of Lead Product
Other/Not Applicable
Number of Unlicensed Products Looking for Licensing
n/a
CEO/Top Company Official
Dr Rahul Gupta, president
When you expect your next catalyst update?
n/a

